Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteosarcoma × IMVP-16 protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Methotrexate 4 Doxorubicin 3 Ifosfamide 2 Etoposide 2 Cisplatin 2 peginterferon alfa-2b 1 merphos 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Specimen Handling 1 Platinum 1 IMVP-16 protocol 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Cyproheptadine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00180908 2005-09-16

Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡